Martínez Moragón E, Menéndez R, Santos M, Lorente R, Marco V
Servicio de Neumología, Hospital Universitario La Fe, Valencia.
Arch Bronconeumol. 1996 Apr;32(4):170-5.
Diseases caused by opportunistic ambient mycobacteria (OAM) are common in HIV-positive patients, although they also occur in immunocompetent individuals. The objective of the present study was to describe the risk factors, clinical signs, course and microbiological spectrum of OAM that cause pulmonary diseases in non HIV-infected individuals in our community. We reviewed 29 consecutive patients with OAM-caused pulmonary disease between 1989-1994 (26 men and 3 women, mean age 58 +/- 14 years). Infections were by Mycobacterium kansasii, 19 (66%) cases; M. avium complex, 7 (24%) cases; M. chelonei, 2 (7%) cases, and M. flavescens, one (3%) case. Risk factors most often associated to infection were smoking and a history of pulmonary disease (chronic obstructive pulmonary disease or residual tuberculosis). Clinical signs were non specific, although toxic syndrome and unproductive cough predominated. Chest films were indistinguishable from those for infection by M. tuberculosis, with cavitated alveolar fibrosis being the main pattern. In vitro drug sensitivity tests showed that all strains were resistant to isoniazid, and that M. avium complex and M. chelonei strains were resistant to rifampicin, streptomycin and, to a lesser degree, to ethambutol. With prolonged medical treatment lasting from 12 to 24 months with first line drugs, outcome was good for the 17 patients for whom full follow-up information was available. Therapy failed to eradicate the bacteria in only 2 patients.
由环境机会性分枝杆菌(OAM)引起的疾病在HIV阳性患者中很常见,不过在免疫功能正常的个体中也会发生。本研究的目的是描述在我们社区中导致非HIV感染个体肺部疾病的OAM的危险因素、临床体征、病程及微生物谱。我们回顾了1989年至1994年间连续的29例由OAM引起的肺部疾病患者(26例男性和3例女性,平均年龄58±14岁)。感染病原菌为堪萨斯分枝杆菌,19例(66%);鸟分枝杆菌复合群,7例(24%);龟分枝杆菌,2例(7%),微黄分枝杆菌,1例(3%)。最常与感染相关的危险因素是吸烟和肺部疾病史(慢性阻塞性肺疾病或陈旧性肺结核)。临床体征不具特异性,不过中毒综合征和干咳较为常见。胸部X线片与肺结核感染难以区分,主要表现为空洞性肺泡纤维化。体外药敏试验显示所有菌株对异烟肼耐药,鸟分枝杆菌复合群和龟分枝杆菌菌株对利福平、链霉素耐药,对乙胺丁醇耐药程度较低。使用一线药物进行12至24个月的长期治疗后,对于有完整随访信息的17例患者,治疗效果良好。仅2例患者的治疗未能根除细菌。